A detailed history of Nierenberg Investment Management Company, Inc. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Nierenberg Investment Management Company, Inc. holds 12,555 shares of CTMX stock, worth $13,433. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,555
Previous 12,555 -0.0%
Holding current value
$13,433
Previous $15,000 6.67%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.21 - $5.13 $15,191 - $64,407
12,555 New
12,555 $15,000

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $70.6M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Nierenberg Investment Management Company, Inc. Portfolio

Follow Nierenberg Investment Management Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nierenberg Investment Management Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nierenberg Investment Management Company, Inc. with notifications on news.